{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:55:59Z","timestamp":1781859359227,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ajoc.2023.101806","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T09:00:47Z","timestamp":1674637247000},"page":"101806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Iris atrophy after administration of Dexycu: Additional evidence and possible mechanism for a rare complication"],"prefix":"10.1016","volume":"30","author":[{"given":"Azraa","family":"Ayesha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-2091","authenticated-orcid":false,"given":"Ryan T.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel G.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-6133","authenticated-orcid":false,"given":"Craig J.","family":"Chaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajoc.2023.101806_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ophtha.2017.12.029","article-title":"Dexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a randomized, placebo-controlled, phase III trial","volume":"125","author":"Donnenfeld","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2023.101806_bib2","volume":"1\u201356","author":"Harris","year":"2017"},{"key":"10.1016\/j.ajoc.2023.101806_bib3","article-title":"Iris atrophy after administration of intracameral Dexycu in routine cataract surgery: a case series","author":"Bergman","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"8 Suppl 1","key":"10.1016\/j.ajoc.2023.101806_bib4","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/IJG.0000000000000104","article-title":"The cellular and molecular biology of the iris, an overlooked tissue: the iris and pseudoexfoliation glaucoma","volume":"23","author":"Borras","year":"2014","journal-title":"J Glaucoma"},{"issue":"6","key":"10.1016\/j.ajoc.2023.101806_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-0749.2005.00268.x","article-title":"Melanin in human irides of different color and age of donors","volume":"18","author":"Wielgus","year":"2005","journal-title":"Pigment Cell Res. Dec"},{"issue":"12","key":"10.1016\/j.ajoc.2023.101806_bib6","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1002\/jcp.29824","article-title":"Molecular and biochemical mechanisms of human iris color: a comprehensive review","volume":"235","author":"Dorgaleleh","year":"2020","journal-title":"J Cell Physiol. Dec"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101806_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archopht.1996.01100130433014","article-title":"Melanocytes and Iris color: light microscopic findings","volume":"114","author":"Wilkerson","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2023.101806_bib8","first-page":"492","article-title":"Linear hypopigmentation and cutaneous atrophy following intra-articular steroid injections for de Quervain's tendonitis","volume":"8","author":"Venkatesan","year":"2009","journal-title":"J Drugs Dermatol. May"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101806_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/2229-5178.142483","article-title":"Side-effects of topical steroids: a long overdue revisit","volume":"5","author":"Coondoo","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"6 Suppl","key":"10.1016\/j.ajoc.2023.101806_bib10","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.4097\/kjae.2013.65.6S.S59","article-title":"Hypopigmentation and subcutaneous fat, muscle atrophy after local corticosteroid injection","volume":"65","author":"Park","year":"2013","journal-title":"Korean J Anesthesiol. Dec"},{"issue":"2","key":"10.1016\/j.ajoc.2023.101806_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4103\/0970-0358.101328","article-title":"Abnormal pigmentation within cutaneous scars: a complication of wound healing","volume":"45","author":"Chadwick","year":"2012","journal-title":"Indian J Plast Surg. May"},{"issue":"8","key":"10.1016\/j.ajoc.2023.101806_bib12","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.drudis.2019.05.035","article-title":"Challenges and opportunities for drug delivery to the posterior of the eye","volume":"24","author":"Cabrera","year":"2019","journal-title":"Drug Discov Today"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:01:32Z","timestamp":1762527692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993623000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":12,"alternative-id":["S2451993623000142"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101806","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iris atrophy after administration of Dexycu: Additional evidence and possible mechanism for a rare complication","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101806"}}